DK681688D0 - Pyrimidonforbindelser og farmaceutisk acceptable salte heraf - Google Patents

Pyrimidonforbindelser og farmaceutisk acceptable salte heraf

Info

Publication number
DK681688D0
DK681688D0 DK681688A DK681688A DK681688D0 DK 681688 D0 DK681688 D0 DK 681688D0 DK 681688 A DK681688 A DK 681688A DK 681688 A DK681688 A DK 681688A DK 681688 D0 DK681688 D0 DK 681688D0
Authority
DK
Denmark
Prior art keywords
pyrimidone
pyrimidon
compounds
acceptable salts
gastric
Prior art date
Application number
DK681688A
Other languages
English (en)
Other versions
DK681688A (da
DK169323B1 (da
Inventor
Fujio Nohara
Original Assignee
Ikeda Mohando Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikeda Mohando Co filed Critical Ikeda Mohando Co
Publication of DK681688D0 publication Critical patent/DK681688D0/da
Publication of DK681688A publication Critical patent/DK681688A/da
Application granted granted Critical
Publication of DK169323B1 publication Critical patent/DK169323B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK681688A 1987-12-07 1988-12-07 Pyrimidonforbindelser og farmaceutisk acceptable salte heraf DK169323B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30929387 1987-12-07
JP62309293A JPH0613486B2 (ja) 1987-12-07 1987-12-07 ピリミドン誘導体及びその医薬的に許容される塩

Publications (3)

Publication Number Publication Date
DK681688D0 true DK681688D0 (da) 1988-12-07
DK681688A DK681688A (da) 1989-06-08
DK169323B1 DK169323B1 (da) 1994-10-10

Family

ID=17991256

Family Applications (1)

Application Number Title Priority Date Filing Date
DK681688A DK169323B1 (da) 1987-12-07 1988-12-07 Pyrimidonforbindelser og farmaceutisk acceptable salte heraf

Country Status (10)

Country Link
US (1) US4956463A (da)
EP (1) EP0319903B1 (da)
JP (1) JPH0613486B2 (da)
KR (1) KR960002557B1 (da)
AT (1) ATE110060T1 (da)
AU (1) AU609229B2 (da)
CA (1) CA1308717C (da)
DE (1) DE3851129T2 (da)
DK (1) DK169323B1 (da)
ES (1) ES2058223T3 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597177A (ja) * 1982-07-06 1984-01-14 Teikoku Hormone Mfg Co Ltd 新規な置換ベンジルアミン誘導体
JO1275B1 (en) * 1982-12-03 1985-04-20 هنري براون ثوماس Chemical process
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
JPS61155373A (ja) * 1984-12-28 1986-07-15 Yamanouchi Pharmaceut Co Ltd 新規な2−置換アミノ−4(1h)−ピリミドン誘導体及びその製造法

Also Published As

Publication number Publication date
KR890009889A (ko) 1989-08-04
JPH01149774A (ja) 1989-06-12
DK681688A (da) 1989-06-08
DE3851129T2 (de) 1994-12-01
KR960002557B1 (ko) 1996-02-22
DE3851129D1 (de) 1994-09-22
EP0319903A3 (en) 1990-07-25
ES2058223T3 (es) 1994-11-01
DK169323B1 (da) 1994-10-10
US4956463A (en) 1990-09-11
AU2656388A (en) 1989-06-08
AU609229B2 (en) 1991-04-26
CA1308717C (en) 1992-10-13
JPH0613486B2 (ja) 1994-02-23
EP0319903B1 (en) 1994-08-17
EP0319903A2 (en) 1989-06-14
ATE110060T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
SE9301830D0 (sv) New compounds
ES8705865A1 (es) Procedimiento para preparar derivados de becimidazol sustituidos en posicion 5
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ZA893086B (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial disease
DK102788A (da) Quinolinforbindelse og dens farmaceutiske anvendelse
DK681688A (da) Pyrimidonforbindelser og farmaceutisk acceptable salte heraf
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
EP0383481A3 (en) Anesthetic oral compositions
PT82847A (de) "4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaure-(n-(3-trifluormethyl-phenyl)-amide)zur antithrombotischen prophylaxe und behanbdlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln
GR852408B (da)
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
EP0227339A3 (en) Xamoterol for the treatment of obesity

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed